Jane Wasman Sellas Life Sciences Group, Inc. (SLS) insider trading activity

SLS Quotes by TradingView

Jane Wasman is Director of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 22,900 shares of SLS, which is worth approximately $23,358. The most recent transaction as insider was on Jan 10, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.9K
120.19% 3M change
420.45% 12M change
Total Value Held $23,358

Jane Wasman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 35.31%
22,900 Common Stock
Jan 22 2024
BUY
Grant, award, or other acquisition
-
6,000 Added 36.59%
10,400 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
2,500 Added 36.23%
4,400 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
1,900 Added 50.0%
1,900 Common Stock

Also insider at

ATHX
ATHERSYS, INC Healthcare
Director
RIGL
RIGEL PHARMACEUTICALS INC Healthcare
JW

Jane Wasman

Director
Cleveland, OH

Track Institutional and Insider Activities on SLS

Follow SELLAS Life Sciences Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLS shares.

Notify only if

Insider Trading

Get notified when an Sellas Life Sciences Group, Inc. insider buys or sells SLS shares.

Notify only if

News

Receive news related to SELLAS Life Sciences Group, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLS